Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
1.330
0.00 (0.00%)
Mar 9, 2026, 2:06 PM EDT - Market open
Vivos Therapeutics Employees
Vivos Therapeutics had 109 employees as of December 31, 2024. The number of employees decreased by 14 or -11.38% compared to the previous year.
Employees
109
Change (1Y)
-14
Growth (1Y)
-11.38%
Revenue / Employee
$66,095
Profits / Employee
-$65,279
Market Cap
13.92M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Trinity Biotech | 401 |
| IRIDEX | 93 |
| Adagio Medical Holdings | 80 |
| Lifeward | 80 |
| Beyond Air | 61 |
| Modular Medical | 54 |
| PAVmed | 39 |
| Movano | 32 |
VVOS News
- 4 weeks ago - Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth's Groundbreaking FDA-Cleared Allergy and Sleep Technologies - GlobeNewsWire
- 4 weeks ago - Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Benzinga
- 6 weeks ago - Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds - GlobeNewsWire
- 7 weeks ago - Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds - GlobeNewsWire
- 2 months ago - Vivos Therapeutics, Inc. (VVOS) Discusses Strategic Business Model Pivot and Transition in Sleep Apnea Treatment Approach Transcript - Seeking Alpha
- 2 months ago - Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan - GlobeNewsWire
- 3 months ago - Vivos Therapeutics, Inc. (VVOS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025 - GlobeNewsWire